Health X Platform Ltd
Q1 FY27, unaudited
- Interest earned
- ₹446.85 Cr
- Profit after tax
- ₹1.99 Cr
As filed with the exchange, consolidated basis.
Statement of profit and loss
Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.
| ₹ crore | Q1 FY27 | vs a year ago | FY26 |
|---|---|---|---|
| Interest earned | 446.85 | +49.73% | 1,319.27 |
| Other income | 12.83 | −49.45% | 58.27 |
| Total income | 459.68 | +41.96% | 1,377.54 |
| Employee benefit expense | 27.68 | +59.65% | 83.97 |
| Provisions & contingencies | — | — | — |
| Profit before tax | 1.97 | −93.46% | -2.36 |
| Tax expense | -0.01 | −100.33% | -0.91 |
| Profit after tax | 1.99 | −92.53% | -1.45 |
| Total comprehensive income | 1.39 | −94.83% | 0.74 |
| Earnings per share, basic | ₹0.80 | ₹0.37 |
|---|---|---|
| Earnings per share, diluted | ₹0.80 | ₹0.37 |
Earnings call
Q4 FY26Health X Platform (formerly Sastasundar Ventures) reported Q4 FY26 revenue of Rs 356 crore, up 22% year-on-year, with EBITDA losses narrowing to Rs 20 crore from Rs 29 crore a year earlier. For the full year, revenue reached Rs 1,283 crore with EBITDA losses reduced to Rs 65 crore and a near breakeven PAT loss of Rs 1.4 crore. Management also discussed the launch of the JITO generic medicine brand, capacity expansion plans, and a proposed demerger of the finance division into a separately listed entity called Microsec Resources.
Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary
Filings
12 shown · 34 published by the exchange
25 Aug 2026
17 Aug 2026
Transcript11 Aug 2026
08 Aug 2026
Filing07 Aug 2026
Presentation07 Aug 2026
Filing07 Aug 2026
07 Aug 2026
05 Aug 2026
03 Aug 2026
30 Jul 2026
09 Jul 2026
BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.
Page generated from filings held to 25 Aug 2026.